What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Core Bone Density & Calcium

STELBONE

Cissus Quadrangularis 750mg + Calcium Citrate 1000mg + Vitamin D3 400 IU + Cyanocobalamin 2.2 mcg

Pack: 10x1x10
Format: Alu-Alu

MRP₹1,771.00

A high-potency orthopedic and regenerative formula designed for accelerated bone healing and the management of osteoporosis. STELBONE combines the natural bone-knitting power of Cissus Quadrangularis with superior Calcium Citrate and essential vitamins to restore bone mineral density and enhance skeletal strength.

About The Product

Key Benefits

Accelerated Fracture Healing

Cissus Quadrangularis 750mg is a potent herbal extract known as the bone-setter. It works by stimulating the metabolism and uptake of calcium by osteoblasts (bone-forming cells), significantly reducing the time required for fracture healing and strengthening the connective tissue around the injury site.

Superior Calcium Absorption

Calcium Citrate 1000mg is a highly bioavailable form of calcium that does not require stomach acid for absorption. This makes STELBONE ideal for patients of all ages, including those with sensitive digestive systems or those taking antacids, ensuring maximum calcium delivery to the skeletal matrix.

Enhanced Bone Mineralization

Vitamin D3 400 IU plays a critical role in the active transport of calcium from the intestines into the bloodstream. By maintaining optimal Vitamin D levels, STELBONE ensures that the high-dose calcium is effectively utilized for bone mineralization rather than being excreted, preventing bone thinning and brittleness.

Neuro-Metabolic Support

Cyanocobalamin 2.2mcg (Vitamin B12) is an essential cofactor for bone-forming cells and DNA synthesis. It helps regulate homocysteine levels, which, when elevated, are associated with a higher risk of bone fractures and osteoporosis, providing an additional layer of protection for skeletal health.

Synergistic Collagen and Matrix Support

The combination of Cissus and Calcium Citrate promotes the synthesis of the collagenous organic matrix of the bone. This ensures that the bone is not just hard, but also resilient and flexible enough to withstand mechanical stress and impact without fracturing.

Comprehensive Management of Osteoporosis

STELBONE is specifically formulated for individuals at risk of low bone density. By addressing both the hormonal and nutritional requirements for bone health, it helps increase Bone Mineral Density (BMD) and provides long-term support for post-menopausal women and geriatric patients.

Indication Bone Fractures and Delayed Union, Osteoporosis and Osteopenia, Post-Menopausal Bone Loss, Drug-Induced Bone Weakness, General Bone and Joint Pain, Calcium and Vitamin D3 Deficiency.

Indications

Bone Fractures and Delayed Union
Osteoporosis and Osteopenia
Post-Menopausal Bone Loss
Drug-Induced Bone Weakness
General Bone and Joint Pain
Calcium and Vitamin D3 Deficiency.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

STELBONE